Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

Detalles Bibliográficos
Autores principales: Gong, Jun, Thomassian, Shant, Kim, Sungjin, Gresham, Gillian, Moshayedi, Natalie, Ye, Jason Y., Yang, Julianne C., Jacobs, Jonathan P., Lo, Simon, Nissen, Nick, Gaddam, Srinivas, Tighiouart, Mourad, Osipov, Arsen, Hendifar, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636406/
https://www.ncbi.nlm.nih.gov/pubmed/36333397
http://dx.doi.org/10.1038/s41598-022-23619-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636406/
https://www.ncbi.nlm.nih.gov/pubmed/36333397
http://dx.doi.org/10.1038/s41598-022-23619-6

Ejemplares similares